480 results on '"El-Sadr W"'
Search Results
102. Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993.
103. The Accurate Diagnosis of Oral Lesions in Human Immunodeficiency Virus Infection: Impact on Medical Staging
104. Intravenous Drug Use or HIV Infection: Which Better Predicts Depression?
105. Unrecognized human immunodeficiency virus infection in the elderly
106. Streptococcus bovis Bacteremia and Meningitis Associated with Strongyloides stercoralis Colitis in a Patient Infected with Human Immunodeficiency Virus
107. Cranial Epidural Abscess Due to Mycobacterium tuberculosis in a Patient Infected with the Human Immunodeficiency Virus
108. Group C Streptococcal Subdural Empyema in a Healthy Man: Possible Complication of Pharyngitis
109. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY
110. The challenge of minority recruitment in clinical trials for AIDS
111. Tuberculosis Knowledge, Attitudes, and Beliefs in Foreign-born and US-born Patients with Latent Tuberculosis Infection.
112. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
113. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
114. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).
115. Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy.
116. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
117. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
118. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050)
119. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
120. Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons.
121. Difference in clinical implications of CD4 counts among HIV-infected homosexual men and injection drug using men and women.
122. Sexual functioning in HIV+ and HIV- injected drug-using women.
123. Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men.
124. Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients
125. HIV Lipodystrophy Case Definition using Artificial Neural Network Modelling
126. Mutations in HIV-1 Reverse Transcriptase during Therapy with Abacavir, Lamivudine and Zidovudine in HIV-1-Infected Adults with No Prior Antiretroviral Therapy
127. Antiretroviral treatment in resource-poor settings: clinical research priorities.
128. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
129. Does diabetes mellitus (DM) confer an equivalent risk of coronary heart disease (CHD) to pre-existing CHD in HIV-positive individuals?
130. Managing early HIV infection. Agency for Health Care Policy and Research
131. Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses
132. Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis
133. Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human
134. Evaluation of sudden death and non-haemorrhagic stroke and their association with HIV protease inhibitor (PI) usage
135. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study
136. Erratum: Hypertension in HIV-infected patients (Antiviral Therapy (2005) 10 (811-823))
137. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
138. Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke
139. Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?
140. A prospective study of predictors for multidrug-resistant tuberculosis among HIV infected patients
141. In vitro immune mechanisms associated with clearance of microfilariae of Dirofilaria immitis.
142. Pneumocystis carinii Infections in Patients with AIDS
143. Four-Year Prospective Study of Homosexual Men: Correlation of Immunologic Abnormalities, Clinical Status, and Serology to Human Immunodeficiency Virus
144. Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa
145. Epidemiology of dual infection with tuberculosis (Tb) and HIV in Harlem
146. Women's sexual risk behavior among parenteral drug users
147. Effect of HIV infection on response to syphilis.
148. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
149. Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort.
150. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.